European Patent Office

T 2003/08 (Dilated cardiomyopathy/EDWARDS) of 31.10.2012

European Case Law Identifier
ECLI:EP:BA:2012:T200308.20121031
Date of decision
31 October 2012
Case number
T 2003/08
Petition for review of
-
Application number
96941378.0
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
T 2003/08 2012-03-30
Abstracts for this decision
-
Application title
Treatment of dilated cardiomyopathy by removal of autoantibodies
Applicant name
Edwards Lifesciences Corporation
Reinke, Petra
Brehme, Stefan
Baumann, Gert
Felix, Stephan
Opponent name
Fresenius Medical Care Deutschland GmbH
Board
3.3.04
Headnote
-
Keywords
"Request not to hear a witness due to failure to reply to the invitation in accordance with Rule 118(c) EPC (refused)";
"Request for referral of questions to the Enlarged Board of Appeal (refused)";
Main request: added subject-matter (yes)
Auxiliary request: claims to be interpreted as relating to a second medical use (yes) - means used in the treatment to be considered as a substance or composition in the sense of decision G 5/83; oral disclosure at a lecture - evidence from the lecturer and a member of the audience may be sufficient to establish the oral disclosure - contrary to the application by the first instance of decision T 1212/97; oral disclosure and prior use - established beyond reasonable doubt (no); conformity of the claims with the requirements of the EPC (yes)
Catchword
see points 6 to 21 and 30 to 48

ORDER

For these reasons it is decided that:

The appeals of both appellants are dismissed.